DADavina C. Angell

Davina C. Angell

*This is an algorithmically generated author record based on publicly available information.

Davina C. Angell has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Annette E Neele

    Department of Medical Biochemistry, Experimental Vascular Biology, Amsterdam Cardiovascular Sciences, Amsterdam Infection and Immunity, Amsterdam UMC, University of Amsterdam , Amsterdam

    1 shared publication
  • Catriona Sharp

    Immuno-Epigenetics, Adaptive Immunity Research Unit, GSK Medicines Research Centre , Stevenage

    1 shared publication
  • Charlotte Ashby

    Immuno-Epigenetics, Adaptive Immunity Research Unit, GSK Medicines Research Centre , Stevenage

    1 shared publication
  • H. Christian Eberl

    Cellzome, a GSK company, Meyerhofstrasse 1, 69117 Heidelberg, Germany

    1 shared publication
  • Inmaculada Rioja

    GlaxoSmithKline 2 Immunology Research Unit Medicines Research Centre, Stevenage, United Kingdom

    1 shared publication
  • Jan Van Den Bossche

    Department of Molecular Cell Biology and Immunology, Amsterdam Cardiovascular Sciences, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam Institute for Infection and Immunity, Cancer Centre Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands

    1 shared publication

Latest Publications

  • IFN-γ Drives Human Monocyte Differentiation into Highly Proinflammatory Macrophages That Resemble a Phenotype Relevant to Psoriasis

    by Rosario Luque-Martin, Davina C. Angell, Mathias Kalxdorf, Sharon Bernard, William Thompson, H. Christian Eberl, Charlotte Ashby, Johannes Freudenberg, Catriona Sharp, Jan Van Den Bossche, et al.

    As key cells of the immune system, macrophages coordinate the activation and regulation of the immune response. Macrophages present a complex phenotype that can vary from homeostatic, proinflammatory, and profibrotic to anti-inflammatory phenotypes. The factors that drive the differentiation from monocyte to macrophage largely define the resultant phenotype, as has been shown by the differences found in M-CSF– and GM-CSF–derived macrophages. We explored alternative inflammatory mediators that could be used for in vitro differentiation of human monocytes into macrophages. IFN-γ is a potent inflammatory mediator produced by lymphocytes in disease and infections. We used IFN-γ to differentiate human monocytes into macrophages and characterized the cells at a functional and proteomic level. IFN-γ alone was sufficient to generate macrophages (IFN-γ Mϕ) that were phagocytic and responsive to polarization. We demonstrate that IFN-γ Mϕ are potent activators of T lymphocytes that produce IL-17 and IFN-γ. We identified potential markers (GBP-1, IP-10, IL-12p70, and IL-23) of IFN-γ Mϕ and demonstrate that these markers are enriched in the skin of patients with inflamed psoriasis. Collectively, we show that IFN-γ can drive human monocyte to macrophage differentiation, leading to bona fide macrophages with inflammatory characteristics.